AMAG Pharmaceuticals Just Filed Its Quarterly Report: The components of b...


The components of basic and diluted net loss per share were as follows (in thousands, except per share data):

 

 

 

Three Months Ended March 31,

 

 

 

2014

 

2013

 

Net loss

 

$

(7,102

)

$

(3,895

)

Weighted average common shares outstanding

 

21,824

 

21,544

 

Net loss per share:

 

 

 

 

 

Basic and diluted

 

$

(0.33

)

$

(0.18

)

 

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

EVP of AMAG Pharmaceuticals just picked up 40,000 shares - Aug. 21, 2014
SVP of AMAG Pharmaceuticals just picked up 20,000 shares - Aug. 21, 2014
SVP of AMAG Pharmaceuticals just picked up 20,000 shares - Aug. 21, 2014
AMAG Pharmaceuticals's President and CEO just picked up 40,000 shares - Aug. 21, 2014
SVP of AMAG Pharmaceuticals just picked up 20,000 shares - Aug. 21, 2014
SVP of AMAG Pharmaceuticals just picked up 20,000 shares - Aug. 21, 2014
AMAG Pharmaceuticals director just picked up 1,900 shares - Aug. 21, 2014

   Auto Refresh

Feedback